Elizabeth Galik, PhD, CRNP
Assistant Professor of Nursing
University of Maryland Schools of Nursing and Medicine
Gary W. Small, MD
Parlow-Solomon Professor on Aging
Professor of Psychiatry and Biobehavioral Sciences
Director, UCLA Center on Aging
Director, Memory and Aging Research Center
Jane and Terry Semel Institute for Neuroscience & Human Behavior
Los Angeles, California
1 contact hour (0.1 CEU)
The burden of Alzheimer's disease (AD) is well known; in the United States, $148 billion dollars is spent on the care of more than 5 million individuals with AD—a number that is expected to climb to 7.7 million people by the year 2030. It is now the sixth leading cause of death in Americans over the age of 65. While current therapies cannot halt the disease, active medical management can significantly improve the quality of life for patients with AD and their caregivers.
Many gerontological advanced practice nurses (APNs) already are aware of the basic concepts behind the evaluation and management of AD. As the number of persons with AD increases, APNs will face more complex management challenges. In addition to reviewing strategies to slow disease progression, this activity will help APNs to determine when and how to add or change therapies to preserve cognitive function and help control behavioral symptoms. Strategies for therapy discontinuation will be discussed. Faculty also will review advances in clinical research and practical considerations regarding the role of these therapies in the management of AD.
NOTE: Participants who received CE credit for attending the live symposium at GAPNA's Annual Educational Conference and Business Meeting in Savannah, Georgia, on October 2, 2009, are not eligible to receive CE credit for this activity.
. Target Audience
This educational activity is designed for advanced practice nurses who care for older adults with Alzheimer's disease.
Upon completion of this educational activity, the participant should be able to:
Discuss the role of resident and family education in the management of AD.
Develop individualized treatment plans for patients with varying severity of AD.
Describe how to evaluate residents with cognitive, functional, and/or behavioral changes and modify treatment for AD accordingly.
Summarize key clinical updates in AD research.
Dr. Galik discloses that she has served on the speaker's bureau for Novartis Pharmaceuticals.
Dr. Small discloses that he has received honoraria for serving as a consultant or speaker for: Abbott Laboratories, Dakim, Eisai, Forest Laboratories, Medivation, Myriad Genetics, Novartis Pharmaceuticals, Ortho-McNeil-Janssen Pharmaceuticals, Pfizer, and Siemens. In addition, he discloses that he owns stock in Dakim; and he is among the inventors and has received royalties and will receive royalties on future sales on the patent publication "Methods for Labeling Beta-Amyloid Plaques and Neurofibrillary Tangles," which has been licensed to Siemens.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This continuing nursing education activity was approved by the Gerontological Advanced Practice Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Participants must attend the entire presentation and submit a completed evaluation to be awarded credit.
There is no fee to participate in this activity.
Program Activity Number A.2009.21 Commercial Support Statements
This activity is supported through an educational grant from Forest Laboratories, Inc.
Please turn off all pop-up blockers.
Click on the "Start program" icon. If you are not already logged in to the site, this will bring you to the login/registration page where you will be able to register as a new cmecorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
Complete the short survey and click on "done."
The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. This activity will require approximately 60 minutes to complete.
After the program has finished, click on the "Post-test" button. Complete the short survey and click on "done."
Instructions for completing and submitting the post-test and program evaluation are provided on the post-test screen. A credit certificate will be awarded for a score of 70% or better and may be printed immediately after passing the post-test.